Literature DB >> 31578606

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal.

C Villa1,2,3, A Vasiljevic4,5,6,7, M L Jaffrain-Rea8,9, O Ansorge10, S Asioli11,12, V Barresi13, L Chinezu14, M P Gardiman15, A Lania16, A M Lapshina17, L Poliani18, L Reiniger19, A Righi20, W Saeger21, J Soukup22, M Theodoropoulou23, S Uccella24, J Trouillas4,5, F Roncaroli25.   

Abstract

The 2017 World Health Organization (WHO) classification proposes to type and subtype primary adenohypophyseal tumours according to their cell lineages with the aim to establish more uniform tumour groups. The definition of atypical adenoma was removed in favour of high-risk adenoma, and the assessment of proliferative activity and invasion was recommended to diagnose aggressive tumours. Recently, the International Pituitary Pathology Club proposed to replace adenoma with the term of pituitary neuroendocrine tumour (PitNET) to better reflect the similarities between adenohypophyseal and neuroendocrine tumours of other organs. The European Pituitary Pathology Group (EPPG) endorses this terminology and develops practical recommendations for standardised reports of PitNETs that are addressed to histo- and neuropathologists. This brief report presents the results of EPPG's consensus for the reporting of PitNETs and proposes a diagnostic algorithm.

Entities:  

Keywords:  European Pituitary Pathology Group; Pituitary neuroendocrine tumours; Standardised diagnostic approach

Mesh:

Substances:

Year:  2019        PMID: 31578606     DOI: 10.1007/s00428-019-02655-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  An algorithmic approach to sellar region masses.

Authors:  B K Kleinschmidt-DeMasters; M B S Lopes; Richard A Prayson
Journal:  Arch Pathol Lab Med       Date:  2015-03       Impact factor: 5.534

Review 2.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

3.  Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification.

Authors:  Gérald Raverot; Emmanuelle Dantony; Julie Beauvy; Alexandre Vasiljevic; Sara Mikolasek; Françoise Borson-Chazot; Emmanuel Jouanneau; Pascal Roy; Jacqueline Trouillas
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

4.  Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth.

Authors:  Etienne Delgrange; Alexandre Vasiljevic; Anne Wierinckx; Patrick François; Emmanuel Jouanneau; Gérald Raverot; Jacqueline Trouillas
Journal:  Eur J Endocrinol       Date:  2015-03-19       Impact factor: 6.664

5.  A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.

Authors:  Jacqueline Trouillas; Pascal Roy; Nathalie Sturm; Emmanuelle Dantony; Christine Cortet-Rudelli; Gabriel Viennet; Jean-François Bonneville; Richard Assaker; Carole Auger; Thierry Brue; Aurélie Cornelius; Henry Dufour; Emmanuel Jouanneau; Patrick François; Françoise Galland; François Mougel; François Chapuis; Laurent Villeneuve; Claude-Alain Maurage; Dominique Figarella-Branger; Gérald Raverot; A Barlier; M Bernier; F Bonnet; F Borson-Chazot; G Brassier; S Caulet-Maugendre; O Chabre; P Chanson; J F Cottier; B Delemer; E Delgrange; L Di Tommaso; S Eimer; S Gaillard; M Jan; J J Girard; V Lapras; H Loiseau; J G Passagia; M Patey; A Penfornis; J Y Poirier; G Perrin; A Tabarin
Journal:  Acta Neuropathol       Date:  2013-02-12       Impact factor: 17.088

Review 6.  Aggressive pituitary tumours and carcinomas: two sides of the same coin?

Authors:  Jacqueline Trouillas; Pia Burman; Ann McCormack; Stephan Petersenn; Vera Popovic; Olaf Dekkers; Gerald Raverot
Journal:  Eur J Endocrinol       Date:  2018-03-27       Impact factor: 6.664

Review 7.  The causes and consequences of pituitary gigantism.

Authors:  Albert Beckers; Patrick Petrossians; Julien Hanson; Adrian F Daly
Journal:  Nat Rev Endocrinol       Date:  2018-12       Impact factor: 43.330

Review 8.  The genetic background of acromegaly.

Authors:  Mônica R Gadelha; Leandro Kasuki; Márta Korbonits
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

9.  Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis.

Authors:  Athanasios Fountas; Aikaterini Lavrentaki; Anuradhaa Subramanian; Konstantinos A Toulis; Krishnarajah Nirantharakumar; Niki Karavitaki
Journal:  J Clin Endocrinol Metab       Date:  2018-12-21       Impact factor: 5.958

10.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842

View more
  17 in total

1.  Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors.

Authors:  Hiba Alzoubi; Simone Minasi; Francesca Gianno; Manila Antonelli; Francesca Belardinilli; Felice Giangaspero; Marie-Lise Jaffrain-Rea; Francesca Romana Buttarelli
Journal:  Endocr Pathol       Date:  2022-01-06       Impact factor: 3.943

Review 2.  Overview of the 2022 WHO Classification of Pituitary Tumors.

Authors:  Sylvia L Asa; Ozgur Mete; Arie Perry; Robert Y Osamura
Journal:  Endocr Pathol       Date:  2022-03-15       Impact factor: 3.943

Review 3.  Aggressive nonfunctioning pituitary neuroendocrine tumors.

Authors:  Sérgio Portovedo; Leonardo Vieira Neto; Christina Maeda Takiya; Leandro Miranda-Alves; Paula Soares; Denise Pires de Carvalho
Journal:  Brain Tumor Pathol       Date:  2022-06-20       Impact factor: 3.154

Review 4.  Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature.

Authors:  C Campana; F Nista; L Castelletti; M Caputo; E Lavezzi; P Marzullo; A Ferrero; G Gaggero; F R Canevari; D C Rossi; G Zona; A Lania; D Ferone; F Gatto
Journal:  J Endocrinol Invest       Date:  2022-02-11       Impact factor: 5.467

Review 5.  High-risk pituitary adenomas and strategies for predicting response to treatment.

Authors:  George Kontogeorgos; Eleni Thodou; Robert Y Osamura; Ricardo V Lloyd
Journal:  Hormones (Athens)       Date:  2022-01-21       Impact factor: 2.885

6.  Gonadotroph Tumors Show Subtype Differences That Might Have Implications for Therapy.

Authors:  Mirela Diana Ilie; Alexandre Vasiljevic; Camille Louvet; Emmanuel Jouanneau; Gérald Raverot
Journal:  Cancers (Basel)       Date:  2020-04-20       Impact factor: 6.639

Review 7.  Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".

Authors:  Kiyohiko Sakata; Kana Fujimori; Satoru Komaki; Takuya Furuta; Yasuo Sugita; Kenji Ashida; Masatoshi Nomura; Motohiro Morioka
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

8.  Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway.

Authors:  Richard A Hickman; Jeffrey N Bruce; Marc Otten; Alexander G Khandji; Xena E Flowers; Markus Siegelin; Beatriz Lopes; Phyllis L Faust; Pamela U Freda
Journal:  Neuropathol Appl Neurobiol       Date:  2020-12-20       Impact factor: 8.090

9.  Management of sellar and parasellar tumors becoming symptomatic during pregnancy: a practical algorithm based on multi-center experience and systematic literature review.

Authors:  Matteo Zoli; Federica Guaraldi; Cesare Zoia; Emanuele La Corte; Sofia Asioli; Daniele Bongetta; Arianna Rustici; Diego Mazzatenta
Journal:  Pituitary       Date:  2020-11-17       Impact factor: 4.107

10.  Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.

Authors:  Beata Rak; Maria Maksymowicz; Monika Pękul; Grzegorz Zieliński
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.